Fundraising Fox

NexImmune

Gaithersburg, US · Founded 2011 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

JS
Jonathan SchneckDirector
AC
Alain CappelutiExecutive Officer, Director
KC
Kenneth CarterExecutive Officer, Director
JN
Janis NaeveDirector
JB
James BarrettDirector

Investors · 2

Pfizer Venture Investments$5M – $20M
Rapha Capital Management, LLCSurfsidevia Kevin M. Slawin · inferred

Reported raises · per SEC filings

Form D private placements
▶$7.8MraisedFeb 2019 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bing YaoDirector
  • Paul D'AngioDirector
  • Scott CarmerExecutive Officer, Director
  • Timothy BertramDirector
  • Alain CappelutiExecutive Officer
  • Alan RoemerDirector
  • Robert SpiegelDirector
  • Tony YaoDirector
Offering amount
$10M
Amount sold
$7.8M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.7MraisedFeb 2018 · 69 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott CarmerExecutive Officer, Director
  • Bing YaoDirector
  • Tony YaoDirector
  • Alain CappelutiExecutive Officer
  • Paul D'AngioDirector
  • Timothy BertramDirector
  • Robert SpiegelDirector
  • Alan RoemerDirector
Offering amount
$25M
Amount sold
$21.7M
Finders' fees
$450K
Placement agents
Trout Capital LLC
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedFeb 2015 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Janis NaeveDirector
  • Jonathan SchneckDirector
  • Alain CappelutiExecutive Officer, Director
  • James BarrettDirector
  • Kenneth CarterExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.